BenzingaAugust 13, 2026 at 10:00 AM NY22 days ago

Jones Trading Maintains Buy on Definium Therapeutics, Raises Price Target to $90

Jones Trading analyst Justin Walsh maintains Definium Therapeutics (NASDAQ:DFTX) with a Buy and raises the price target from $74 to $90.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Companies in This Story